• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西血液透析患者五年生存率评估:3082例新发病例队列研究

Assessment of a five-year survival on hemodialysis in Brazil: a cohort of 3,082 incident patients.

作者信息

Matos Jorge Paulo Strogoff de, Almeida Jorge Reis, Guinsburg Adrian, Marelli Cristina, Barra Ana Beatriz Lesqueves, Vasconcellos Marcos Sandro, José D'Almeida Filho Eufrônio, Hoette Marcos, Ruzany Frederico, Lugon Jocemir Ronaldo

机构信息

Division of Nephrology, Faculdade de Medicina, Universidade Federal Fluminense, Niterói, Brazil.

出版信息

J Bras Nefrol. 2011 Dec;33(4):436-41.

PMID:22189807
Abstract

Brazil has the third largest contingent of patients on maintenance hemodialysis (HD) worldwide. However, little is known regarding survival rate and predictors of mortality risk in that population, which are the purposes of this study. A total of 3,082 patients incident on HD, from 2000 to 2004, at 25 dialysis facilities distributed among 7 out of 26 states of Brazil were followed-up until 2009. Patients were 52 ± 16 years-old, 57.8% men, and 20.4%, diabetics. The primary outcome was all causes of mortality. Data were censored at five years of follow-up. The global five-year survival rate was 58.2%. In the Cox proportional model, variables associated with risk of death were: age (hazard ratio - HR = 1.44 per decade, p < 0.0001), diabetes (HR = 1.51, p < 0.0001), serum albumin (HR = 0.76 per g/dL, p = 0.001), creatinine (HR = 0.92 per mg/dL, p < 0.0001), and phosphorus (HR = 1.06 per mg/dL, p = 0.04). The present results show that the mortality rate on HD in this Brazilian cohort was relatively low, but the population is younger and with a lower prevalence of diabetes than the ones reported for developed countries.

摘要

巴西是全球接受维持性血液透析(HD)患者数量第三多的国家。然而,关于该人群的生存率及死亡风险预测因素却知之甚少,而这正是本研究的目的所在。对2000年至2004年间在巴西26个州中7个州的25家透析机构开始接受HD治疗的3082例患者进行随访,直至2009年。患者年龄为52±16岁,男性占57.8%,糖尿病患者占20.4%。主要结局为各种原因导致的死亡。随访数据在5年时进行截尾。全球5年生存率为58.2%。在Cox比例模型中,与死亡风险相关的变量有:年龄(风险比 - HR = 每增加十岁为1.44,p < 0.0001)、糖尿病(HR = 1.51,p < 0.0001)、血清白蛋白(HR = 每克/分升为0.76,p = 0.001)、肌酐(HR = 每毫克/分升为0.92,p < 0.0001)以及磷(HR = 每毫克/分升为1.06,p = 0.04)。目前的结果表明,该巴西队列中HD患者的死亡率相对较低,但与发达国家报道的人群相比,该人群更年轻且糖尿病患病率更低。

相似文献

1
Assessment of a five-year survival on hemodialysis in Brazil: a cohort of 3,082 incident patients.巴西血液透析患者五年生存率评估:3082例新发病例队列研究
J Bras Nefrol. 2011 Dec;33(4):436-41.
2
Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.在拉丁美洲的一个大型透析患者样本中,钙、磷、PTH 与死亡率的关系。CORES 研究。
Nephrol Dial Transplant. 2011 Jun;26(6):1938-47. doi: 10.1093/ndt/gfq304. Epub 2010 May 31.
3
Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.透析患者血清白蛋白与死亡率之间的关联部分可由炎症解释,而非营养不良。
J Ren Nutr. 2009 Mar;19(2):127-35. doi: 10.1053/j.jrn.2008.08.003.
4
Nutritional parameters and mortality in incident hemodialysis patients.新发血液透析患者的营养参数与死亡率
J Ren Nutr. 2006 Jan;16(1):27-35. doi: 10.1053/j.jrn.2005.10.003.
5
Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).透析预后与实践模式研究(DOPPS)中美国新入组血液透析患者早期死亡的预测因素。
Clin J Am Soc Nephrol. 2007 Jan;2(1):89-99. doi: 10.2215/CJN.01170905. Epub 2006 Nov 29.
6
Cardiac surgery in patients on dialysis: decreased 30-day mortality, unchanged overall survival.透析患者的心脏手术:30天死亡率降低,总生存率不变。
Ann Thorac Surg. 2008 Jan;85(1):147-53. doi: 10.1016/j.athoracsur.2007.08.048.
7
Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.腹膜透析和肾移植。在综合肾脏替代治疗模式中的一张双向票。
Nefrologia. 2011;31(4):441-8. doi: 10.3265/Nefrologia.pre2011.May.10898.
8
Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.血液透析中死亡率与住院率的关联:潜在可干预的实验室指标及血管通路
Am J Kidney Dis. 2009 Jan;53(1):79-90. doi: 10.1053/j.ajkd.2008.07.031. Epub 2008 Oct 18.
9
Vascular access for hemodialysis: the impact on morbidity and mortality.血液透析的血管通路:对发病率和死亡率的影响。
J Nephrol. 2004 Jan-Feb;17(1):19-25.
10
Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.脑利钠肽在血液透析患者传统和非传统危险因素之间的作用:对两年随访中心血管死亡率的分析。
Nephron Clin Pract. 2011;119(2):c162-70. doi: 10.1159/000327615. Epub 2011 Jul 8.

引用本文的文献

1
Comparison of 1-year survival between patients initiating chronic hemodialysis under public and private health insurance: register-based data analysis from Brazil.比较公共和私人医疗保险下开始慢性血液透析的患者 1 年生存率:来自巴西的基于登记数据的分析。
Int Urol Nephrol. 2024 Sep;56(9):3013-3022. doi: 10.1007/s11255-024-04018-4. Epub 2024 Apr 5.
2
Impact of initial dialysis modality on the survival of patients with ESRD: a propensity-score-matched study.初始透析模式对终末期肾病患者生存的影响:一项倾向评分匹配研究。
BMC Nephrol. 2023 Oct 26;24(1):313. doi: 10.1186/s12882-023-03312-0.
3
Characteristics and 1-year survival of incident patients on chronic peritoneal dialysis compared with hemodialysis:a large 11-year cohort study.
慢性腹膜透析与血液透析新发病例患者的特征及1年生存率:一项为期11年的大型队列研究
Int Urol Nephrol. 2023 Aug;55(8):2025-2033. doi: 10.1007/s11255-023-03489-1. Epub 2023 Feb 21.
4
Characteristics and predictors of mortality on haemodialysis in Brazil: a cohort of 5,081 incident patients.巴西血液透析患者的死亡率特征及其预测因素:一项 5081 例新发病例患者的队列研究。
BMC Nephrol. 2022 Feb 23;23(1):77. doi: 10.1186/s12882-022-02705-x.
5
Effects of dialysis modality choice on the survival of end-stage renal disease patients in southern China: a retrospective cohort study.透析方式选择对中国南方地区终末期肾病患者生存的影响:一项回顾性队列研究。
BMC Nephrol. 2020 Sep 24;21(1):412. doi: 10.1186/s12882-020-02070-7.
6
Survival Rate and Predictors of Mortality among Hemodialysis Patients in West of Iran, 1996-2015.1996 - 2015年伊朗西部血液透析患者的生存率及死亡预测因素
Int J Prev Med. 2018 Dec 24;9:113. doi: 10.4103/ijpvm.IJPVM_399_16. eCollection 2018.
7
Comparison of patient survival between hemodialysis and peritoneal dialysis in a single Chinese center.中国单一中心血液透析与腹膜透析患者生存率的比较。
Int Urol Nephrol. 2014 Dec;46(12):2403-7. doi: 10.1007/s11255-014-0819-6. Epub 2014 Sep 16.
8
Survival and predictive factors of lethality in hemodialysis: D/I polymorphism of the angiotensin I-converting enzyme and of the angiotensinogen M235T genes.血液透析中致死率的生存及预测因素:血管紧张素I转换酶和血管紧张素原M235T基因的D/I多态性
Arq Bras Cardiol. 2014 Sep;103(3):209-19. doi: 10.5935/abc.20140105. Epub 2014 Jul 29.
9
Prevalence of cardiovascular risk factors in hemodialysis patients - The CORDIAL study.血液透析患者心血管危险因素的患病率——CORDIAL研究
Arq Bras Cardiol. 2014 May;102(5):473-80. doi: 10.5935/abc.20140048. Epub 2014 Apr 17.